Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Immunoprecise Antibodies Ltd IPA

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem... see more

NDAQ:IPA - Post Discussion

Immunoprecise Antibodies Ltd > anything going on
View:
Post by Dragon1 on May 31, 2021 6:39pm

anything going on

Next financials or any kind of news,we seem to be heading for a very sluggish summer.
Comment by wallpaper2 on Jun 03, 2021 11:34am
Moving on, not going on.The pump and dump is over. The people privy, have they moved on. Subscribers and followers of the various advisories such as Jonahs and Pauls appear to have moved on. Pharmas were not interested enough to pay up on Jennifers game changing cocktail for the covid virus or cancer treatments. The inhouse studies done by IPA's lab and published by Jennifer were not the ...more  
Comment by dart321 on Jun 03, 2021 12:04pm
Hi Wallpaper2, one only has to look at the EPS of -0.22 cents per share and a PE/ratio of -41.1 then look at future sales possibilities. The truth is there for all to see,this was a perfect short and still is. My guess the bottom will be 2 bucks give or take a few cents.
Comment by Driven on Jun 04, 2021 11:50am
This post has been removed in accordance with Community Policy
Comment by DanChilds on Jun 04, 2021 11:43pm
How do you feel about their CSO just resigning?  I don't love in that in that anouncement, they say they are a "leader" in therapeutics in the same breadth  that they admit they lost Dr. Adiche. More like they have the potential to be a player if and when they get a single therapeutic product, which seems less likely now. 
Comment by Driven on Jun 05, 2021 11:33am
This post has been removed in accordance with Community Policy
Comment by wallpaper2 on Jun 05, 2021 2:42pm
Same group, same pattern, repeated over and over. Shameful and no morals. If you are part of the inside group you made a ton. General public strung along in my opinion. Disappointed in Jennifer.
Comment by dart321 on Jun 06, 2021 12:14pm
wally, the PE/Ratio and the EPS tell the truth, a company can not hide that. I see no pathway to any change going forward it's the reason I shorted this stock between $25 and $26, it was the second time in my life I ever shorted a stock. I covered a short time ago but it was hard to decide to do it. Still think it drops to $2/$3.  
Comment by 007dave on Jun 06, 2021 1:22pm
You guys are idiots. So you just happened to short it at it's all time high. Since it was only up there for a short cup of coffee you must of shorted a couple dozen shares cause this stock only has about 90,000 shares shorted and hardly trades any significant volume. Currently the bots control the bids and easily walk it up or down. As far as earnings and eps. I guess you should be short GME ...more  
Comment by Playoff on Jun 07, 2021 1:13pm
This post has been removed in accordance with Community Policy
Comment by 007dave on Jun 07, 2021 2:59pm
Which master pumper are you referring to. IPA has been around along time and 90% of the executives are women and science based. Which is one reason the stock is down right now. IPA needs more market people that understand capital markets. They're on the NASDAQ now and need to step up their game.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities